The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
G PROTEINS: TRANSDUCERS OF RECEPTOR-GENERATED SIGNALS
Gilman, A. G. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.003151 · Cited by 6,381
Molecular tinkering of G protein-coupled receptors: an evolutionary success
Bockaert, J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.7.1723 · Cited by 1,550
Ji, T. H., Grossmann, M., & Ji, I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.28.17299 · Cited by 1,277
Uncovering Molecular Mechanisms Involved in Activation of G Protein-Coupled Receptors
Gether, U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0390 · Cited by 1,263
Scrocchi, L. A., Brown, T. J., Maclusky, N., Brubaker, P. L., Auerbach, A. B., Joyner, A. L., & Drucker, D. J. (1996) · Nature Medicine · doi:10.1038/nm1196-1254 · Cited by 793 · cited 5×
“As an exception, the analysis of the GLP-1R knock-out mouse revealed an unexpected role of the constitutively active GPCR in achieving nor- moglycemia following intraperitoneal glucose challenge (Scrocchi et al. 1996).”
BackgroundResultInfluentialShenker, A., Laue, L., Kosugi, S., Merendino, J. J., Minegishi, T., & Cutler, G. B. (1993) · Nature · doi:10.1038/365652a0 · Cited by 745
Thorens, B., Porret, A., Bühler, L., Deng, S.-P., Morel, P., & Widmann, C. (1993) · Diabetes · doi:10.2337/diab.42.11.1678 · Cited by 558
The two-state model of receptor activation
Leff, P. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)88989-0 · Cited by 488
Ango, F., Prézeau, L., Muller, T., Tu, J. C., Xiao, B., Worley, P. F., Pin, J. P., Bockaert, J., & Fagni, L. (2001) · Nature · doi:10.1038/35082096 · Cited by 410
Inverse, protean, and ligand‐selective agonism: matters of receptor conformation
KENAKIN, T. (2001) · The FASEB Journal · doi:10.1096/fj.00-0438rev · Cited by 408
AgRP(83-132) Acts as an Inverse Agonist on the Human-Melanocortin-4 Receptor
Nijenhuis, W. A. J. (2001) · Molecular Endocrinology · doi:10.1210/me.15.1.164 · Cited by 406
Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness
Rao, V. R., Cohen, G. B., & Oprian, D. D. (1994) · Nature · doi:10.1038/367639a0 · Cited by 382
Duprez, L., Parma, J., Van Sande, J., Allgeier, A., Leclère, J., Schvartz, C., Delisle, M.-J., Decoulx, M., Orgiazzi, J., Dumont, J., et al. (1994) · Nature Genetics · doi:10.1038/ng0794-396 · Cited by 379
Inverse agonist activity of beta-adrenergic antagonists.
Chidiac, P., Hebert, T. E., Valiquette, M., Dennis, M., & Bouvier, M. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10022-9 · Cited by 372
RNA Editing of the Human Serotonin 5-Hydroxytryptamine 2C Receptor Silences Constitutive Activity
Niswender, C. M., Copeland, S. C., Herrick-Davis, K., Emeson, R. B., & Sanders-Bush, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9472 · Cited by 363
Dryja, T. P., Berson, E. L., Rao, V. R., & Oprian, D. D. (1993) · Nature Genetics · doi:10.1038/ng0793-280 · Cited by 341
Liu, G., Duranteau, L., Carel, J.-C., Monroe, J., Doyle, D. A., & Shenker, A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912023412304 · Cited by 281
Cloning and Characterization of a Novel Human Histamine Receptor
Morse, K. L., Behan, J., Laz, T. M., West, R. E., Greenfeder, S. A., Anthes, J. C., Umland, S., Wan, Y., Hipkin, R. W., Gonsiorek, W., et al. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38851-2 · Cited by 280
High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype.
Tiberi, M., & Caron, M. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)46876-7 · Cited by 265
Haskell-Luevano, C., & Monck, E. K. (2001) · Regulatory Peptides · doi:10.1016/s0167-0115(01)00234-8 · Cited by 252
Smit, M. J., Leurs, R., Alewijnse, A. E., Blauw, J., Van Nieuw Amerongen, G. P., Van De Vrede, Y., Roovers, E., & Timmerman, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6802 · Cited by 242
Structural and functional aspects of G protein-coupled receptor oligomerization
Hébert, T. E., & Bouvier, M. (1998) · Biochemistry and Cell Biology · doi:10.1139/bcb-76-1-1 · Cited by 223
Iwamura, H., Suzuki, H., Ueda, Y., Kaya, T., & Inaba, T. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38760-9 · Cited by 200
Claeysen, S., Sebben, M., Becamel, C., Bockaert, J., & Dumuis, A. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23188-6 · Cited by 197
G-protein diseases furnish a model for the turn-on switch
Iiri, T., Farfel, Z., & Bourne, H. R. (1998) · Nature · doi:10.1038/27831 · Cited by 195
Alewijnse, A. E., Timmerman, H., Jacobs, E. H., Smit, M. J., Roovers, E., Cotecchia, S., & Leurs, R. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26497-x · Cited by 191
Pan, X., Ikeda, S. R., & Lewis, D. L. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.6.1064 · Cited by 185
BAY36-7620: A Potent Non-Competitive mGlu1 Receptor Antagonist with Inverse Agonist Activity.
Carroll, F. Y., Stolle, A., Beart, P. M., Voerste, A., Brabet, I., Mauler, F., Joly, C., Antonicek, H., Bockaert, J., Müller, T., et al. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.5.965 · Cited by 171
Burger, M., Burger, J. A., Hoch, R. C., Oades, Z. G., Takamori, H., & Schraufstätter, I. U. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.2017 · Cited by 167
Tian, W. N., Duzic, E., Lanier, S. M., & Deth, R. C. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10026-6 · Cited by 161
Role of subunit diversity in signaling by heterotrimeric G proteins
Hildebrandt, J. D. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00269-4 · Cited by 153
Wieland, K., Bongers, G., Yamamoto, Y., Hashimoto, T., Yamatodani, A., Menge, W. M. P. B., Timmerman, H., Lovenberg, T. W., & Leurs, R. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29209-0 · Cited by 144
Rauser, L., Savage, J. E., Meltzer, H. Y., & Roth, B. L. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29304-6 · Cited by 144
Constitutive Activation of Opsin by Mutation of Methionine 257 on Transmembrane Helix 6
Han, M., Smith, S. O., & Sakmar, T. P. (1998) · Biochemistry · doi:10.1021/bi980147r · Cited by 143
Geras‐Raaka, E., Varma, A., Ho, H. H., Clark‐Lewis, I., & Gershengorn, M. C. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.405 · Cited by 133
Gurwitz, D., Haring, R., Heldman, E., Fraser, C. M., Manor, D., & Fisher, A. (1994) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(94)90220-8 · Cited by 129
Pei, G., Samama, P., Lohse, M. J., Wang, M., Codina, J., & Lefkowitz, R. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2699 · Cited by 125
Xie, Z., Lee, S. P., O’Dowd, B. F., & George, S. R. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00918-7 · Cited by 124
Roka, F., Brydon, L., Waldhoer, M., Strosberg, A. D., Freissmuth, M., Jockers, R., & Nanoff, C. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.5.1014 · Cited by 115
Serre‐Beinier, V., Dolci, W., Schaerer, E., Scrocchi, L. A., Drucker, D. J., Efrat, S., & Thorens, B. (1998) · Endocrinology · doi:10.1210/endo.139.11.6295 · Cited by 113
Use of Constitutive G Protein-Coupled Receptor Activity for Drug Discovery
Chen, G., Way, J. M., Armour, S. L., Watson, C., Queen, K., Jayawickreme, C. K., Chen, W. J., & Kenakin, T. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26450-6 · Cited by 111
G proteins of the Gq family couple the H2 histamine receptor to phospholipase C
Kühn, B., Schmid, A., Harteneck, C., Gudermann, T. W., & Schultz, G. (1996) · Molecular Endocrinology · doi:10.1210/me.10.12.1697 · Cited by 97
Biebermann, H., Schöneberg, T., Schulz, A. M., Krause, G., Grüters, A., Schultz, G., & Gudermann, T. W. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.14.1461 · Cited by 95
Yano, K., Saji, M., Hidaka, A., Moriya, N., Okuno, A., Kohn, L. D., & Cutler, G. B. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.4.1162 · Cited by 86
Siegrist, W., Drozdz, R., Cotti, R., Willard, D. H., Wilkison, W. O., & Eberlé, A. N. (1997) · Journal of Receptors and Signal Transduction · doi:10.3109/10799899709036595 · Cited by 86
Leeb-Lundberg, L. M. F., Mathis, S. A., & Herzig, M. C. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47145-1 · Cited by 83
Distinct Interaction of Human and Guinea Pig Histamine H2-Receptor with Guanidine-Type Agonists
Kelley, M. T., Bürckstümmer, T., Wenzel‐Seifert, K., Dove, S., Buschauer, A., & Seifert, R. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.6.1210 · Cited by 73
Self-citationMechanisms of Agonism and Inverse Agonism at Serotonin 5‐HT1A Receptors
McLoughlin, D. J., & Strange, P. G. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740347.x · Cited by 61
Constitutive activity of human prostaglandin E receptor EP3 isoforms
Jin, J., Mao, G. F., & Ashby, B. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701121 · Cited by 59
The Luteinizing Hormone Receptor Activates Phospholipase C via Preferential Coupling to Gi2
Kühn, B., & Gudermann, T. W. (1999) · Biochemistry · doi:10.1021/bi990755m · Cited by 50
Kosugi, S., Shenker, A., & Mori, T. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)01286-5 · Cited by 44
Nilsson, C. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00156-8 · Cited by 36
Roberts, C., Hatcher, P. D., Hagan, J. J., et al. (2000) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100000276 · Cited by 24
Cited by
Structure-Function of the G Protein–Coupled Receptor Superfamily
Katritch, V., Cherezov, V., & Stevens, R. C. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-032112-135923 · Cited by 1,054
The neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 965
Kristiansen, K. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.05.002 · Cited by 609
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Allosteric sodium in class A GPCR signaling
Katritch, V., Fenalti, G., Abola, E. E., Roth, B. L., Cherezov, V., & Stevens, R. C. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.03.002 · Cited by 511
Metadata
- Authors
- Seifert, R., & Wenzel-Seifert, K.
- Venue
- Naunyn-Schmiedeberg's Archives of Pharmacology
- Published
- 2002-11-01
- Volume
- 366
- Issue
- 5
- Pages
- 381-416
- ISSN
- 0028-1298 (ISSN-L)
- 1432-1912
- OpenAlex
- W2023724239
- Cited by
- 637
- References
- 53
- FWCI
- 10.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.